CIK 0000771856
- Non-accelerated filer
- Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521401755
- Phone
- +1 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- 4 Open-market buy Director bought 5,000 shares at $6.22 ($31,100)
- 4 Open-market buy Director bought 1,500 shares at $5.95 ($8,925)
- 4 Open-market buy Director bought 5,000 shares at $6.40 ($32,000)
- 4 Open-market buy Director bought 1,100 shares at $6.41 ($7,051)
- 4 Open-market buy Director bought 1,530 shares at $6.48 ($9,914)
- 4 Open-market buy Director bought 2,000 shares at $6.47 ($12,940)
- 4 Open-market buy Director bought 2,500 shares at $6.30 ($15,750)
- 4 Open-market buy Director bought 5,000 shares at $6.40 ($32,000)
- 4 Open-market buy Director bought 5,000 shares at $5.65 ($28,250)
- 4 Open-market buy Director bought 5,000 shares at $5.28 ($26,400)
- 4 Open-market buy Director bought 4,018 shares at $5.51 ($22,139)
- 4 Open-market buy Director bought 5,000 shares at $5.51 ($27,550)
- 4 Open-market buy Director bought 3,812 shares at $5.50 ($20,966)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 12,382 shares at $4.04 ($49,969)
- 4 Option exercise Director acquired 16,667 shares (option exercise)
Page 3 of 13 · 245 filings